NetworkNewsBreaks Archive - Page 770 of 771

MondaySep 26, 2016 10:56 am

Array BioPharma, Inc. (ARRY) Reports Top-Line Results from Phase 3 Study

Array BioPharma, Inc. (NASDAQ: ARRY) jointly announced with Pierre Fabre the results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used with MEK162 in BRAF Mutant Unresectable Skin Cancer) study evaluating LGX818 (encorafenib), a BRAF inhibitor, and MEK162 (binimetinib), a MEK inhibitor, in patients with BRAF-mutant advanced, unresectable or metastatic melanoma. The study met its primary endpoint, meaningfully improving progression free survival (PFS) compared with vemurafenib, a BRAF inhibitor, alone. To view the full press release, visit: http://nnw.fm/iV5kO About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small…

MondaySep 26, 2016 10:55 am

Limelight Networks, Inc. (LLNW) Selected to Deliver Video Services to Millions of Subscribers

Limelight Networks, Inc. (NASDAQ: LLNW) announced that GoChina TV selected the company to provide over-the-top (OTT) video service to millions of subscribers worldwide. GoChina TV CEO indicated that the Limelight content delivery network (CDN) is superior to other CDNs tried in the past. Excellent local technical support was also a key factor. GoChina TV will benefit greatly from having a reliable and intuitive platform from Limelight that can scale as needed to accommodate an increasing number of subscribers and high quality content. To view the full press release, visit: http://nnw.fm/GDj5A About Limelight Networks Limelight is a top tier content delivery…

FridaySep 23, 2016 1:27 pm

Cowen Group, Inc.’s (COWN) Prime Services Division Wins another Hedgeweek Award

Cowen Group (NASDAQ: COWN) this morning announced that its Cowen Prime Services LLC division was named Best North American Prime Broker at the 2016 Hedgeweek USA Awards. The award is based on a peer review system with the top performer of each category selected by Hedgeweek’s audience of institutional and high net worth investors, hedge fund managers and other industry professionals at fund administrators, prime brokers, law firms, custodians and advisers. This the second consecutive year, and the third in four, that Cowen Prime has received this award. Additionally, Cowen Prime earlier this year was named “Best Global Prime Broker”…

FridaySep 23, 2016 1:24 pm

Aehr Test Systems (AEHR) Announces Private Placement, Posts Preliminary Q1 2017 Financial Results

Aehr Test Systems (NASDAQ: AEHR) has signed a definitive purchase agreement for the sale of approximately $5.9 million in shares of its common stock (priced at $2.15 per share) in a private placement transaction with certain institutional and accredited investors. The supplier of semiconductor test and burn-in equipment plans to use the net proceeds for working capital and general corporate purposes. Aehr also announced preliminary financial results for Q1 of fiscal 2017, expecting a GAAP net loss between $800,000 and $900,000 on revenue of $5.3 million, compared to a net loss of $3.1 million on revenue of $1.6 million in Q4…

FridaySep 23, 2016 1:22 pm

BioLineRx (BLRX) In-Licenses Novel Treatment for Liver Failure Conditions

BioLineRx Ltd. (NASDAQ/TASE: BLRX) this morning said it has entered into an exclusive, worldwide agreement with BGN Technologies, the Technology Transfer Company of Ben-Gurion University, and Hadasit, the Technology Transfer Company of Hadassah Medical Organization, regarding the in-licensing of BL-1220 for the treatment of liver pathologies. BL-1220 marks BioLineRx’s second project in-licensed under its collaboration with Novartis Pharma AG (NYSE: NVS) for the screening and development of novel drug candidates. "In August this year, we in-licensed the first compound under our multi-year strategic partnership with Novartis … Today, we are pleased to announce the second compound under the Novartis collaboration…

FridaySep 23, 2016 1:19 pm

Laguna Blends, Inc. (LAG) (LAGBF) (LB6A.F) Joins Canadian Securities Exchange Composite Index

Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) this morning announced its inclusion to the CSE Composite index, reflecting the network marketing company’s aggressive expansion strategy. "Inclusion in the CSE Composite index is another indicator Laguna continues to deliver shareholder value through its strategic growth strategy. Laguna has positioned itself to be a dominant player in the distribution and marketing of unique hemp and CBD related products around the world," Bryan Loree, CFO of Laguna Blends, stated in the news release. Laguna Blends uses a network of independent affiliates to market its hemp-based functional beverages, and is exclusively licensed…

ThursdaySep 22, 2016 2:09 pm

Terra Tech Corp.’s (TRTC) Edible Garden Begins Shipping Herb Line to Latest Customer

Terra Tech (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, this morning announced that its Edible Garden subsidiary has commenced shipping of its line of 4-inch potted living herbs to nationwide supermarket chain Wegmans Food Markets, Inc. Edible Garden is a retail seller of locally grown hydroponic produce, herbs and floral products. Its living potted herbs are USDA-certified organic and without contaminants, pesticides and GMOs. The company says that since Q2 2016 it has more than tripled production of its herb line in response to supermarket demand and increasing popularity among consumers. “As a result of the popularity of this…

ThursdaySep 22, 2016 2:08 pm

New Jersey Mining Company (NJMC) Discovers New Footwall Vein, Updates on Golden Chest Mine Project

Idaho-based New Jersey Mining Company (OTCQB: NJMC) this morning reported its discovery of a new footwall vein (the “Stevens Vein”). Pit excavation revealed three veins in the pit area: a hanging wall vein thought to be the Jumbo vein, the Idaho vein, and the Stevens Vein. On the 1096 bench, trench sampling has shown the Stevens Vein and the Idaho Vein to be at least three meters wide with a grade of 15.2 grams per tonne (gpt) gold, and approximately two meters (true thickness) with a grade of 4.0 gpt gold, respectively. The company also provided an update on open…

ThursdaySep 22, 2016 2:03 pm

Antares Pharma, Inc. (ATRS) Reports Safety Data from QuickShot Testosterone Clinical Program

Antares Pharma (NASDAQ: ATRS) today announced 26-week safety data from the phase 3 study of QuickShot® Testosterone (QST) administered subcutaneously once each week to adult males with hypogonadism. The study, QST-15-005, showed that the most common adverse reactions (incidence ≥5%) were increased hematocrit, upper respiratory tract infection and injection site ecchymosis. The company reports four patients with treatment emergent serious adverse events (SAEs), which included one patient with transient visual impairment determined not to be drug related; one patient with appendicitis that was not drug related; one patient with deep vein thrombosis (DVT), which the investigator attributed DVT as possibly…

ThursdaySep 22, 2016 1:59 pm

Anavex Life Sciences Corp. (AVXL) Presents Positive Initial Data for Parkinson’s Disease Drug Candidate

At the World Parkinson Congress 2016 in Portland earlier today, Anavex Life Sciences (NASDAQ: AVXL) presented preclinical data in a poster titled “Investigating the potential neurorestorative effects of a clinical Sigma-1 receptor agonist in a mouse model of Parkinson’s disease.” Initial data demonstrated that the company’s ANAVEX 2-73, a sigma-1 receptor agonist, restores function in a classic animal model of Parkinson’s disease. The company reports “significant” improvements across the board, including behavioral, histopathological, and neuroinflammatory endpoints. “This initial data is encouraging, and together with already available clinical safety and tolerability data on ANAVEX 2-73, might accelerate the exploration of ANAVEX…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks